These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15295419)

  • 1. The impact of caffeine on vasodilator stress perfusion studies.
    Lapeyre AC; Goraya TY; Johnston DL; Gibbons RJ
    J Nucl Cardiol; 2004; 11(4):506-11. PubMed ID: 15295419
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging.
    Cosmai EM; Heller GV
    J Nucl Cardiol; 2005; 12(4):466-72. PubMed ID: 16084436
    [No Abstract]   [Full Text] [Related]  

  • 3. Buccal caffeine for the routine reversal of Persantine.
    Matangi M; Dutchak P
    J Nucl Cardiol; 2014 Oct; 21(5):1039. PubMed ID: 24980451
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis.
    Lee JC; Fraser JF; Barnett AG; Johnson LP; Wilson MG; McHenry CM; Walters DL; Warnholtz CR; Khafagi FA
    J Nucl Cardiol; 2012 Jun; 19(3):474-81. PubMed ID: 22302182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
    Tejani FH; Thompson RC; Iskandrian AE; McNutt BE; Franks B
    J Nucl Cardiol; 2011 Feb; 18(1):73-81. PubMed ID: 21082298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine.
    Reyes E; Loong CY; Harbinson M; Donovan J; Anagnostopoulos C; Underwood SR
    J Am Coll Cardiol; 2008 Dec; 52(24):2008-16. PubMed ID: 19055993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic stress testing: new methods and new agents.
    Hendel RC; Jamil T; Glover DK
    J Nucl Cardiol; 2003; 10(2):197-204. PubMed ID: 12673185
    [No Abstract]   [Full Text] [Related]  

  • 8. The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging.
    Bajaj NS; Singh S; Farag A; El-Hajj S; Heo J; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2016 Jun; 23(3):390-413. PubMed ID: 26940574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m N-NOET: Chronicle of a unique perfusion imaging agent and a missed opportunity?
    Vanzetto G; Fagret D; Ghezzi C
    J Nucl Cardiol; 2004; 11(6):647-50. PubMed ID: 15592185
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial perfusion scintigraphy with pharmacological stress. Gruppo Italiano di Cardiologia Nucleare (ANMCO-AIMN).
    G Ital Cardiol; 1995 Jun; 25(6):745-52. PubMed ID: 7649424
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of pharmacologic stress testing for myocardial perfusion imaging.
    Cerqueira Mde C
    Rev Port Cardiol; 2000 Feb; 19 Suppl 1():I23-8. PubMed ID: 10750436
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia.
    Bøttcher M; Refsgaard J; Madsen MM; Randsbaek F; Kaltoft A; Bøtker HE; Nielsen TT
    J Nucl Cardiol; 2003; 10(4):345-52. PubMed ID: 12900738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum caffeine levels after 24-hour abstention: clinical implications on dipyridamole (201)Tl myocardial perfusion imaging.
    Zheng XM; Williams RC
    J Nucl Med Technol; 2002 Sep; 30(3):123-7. PubMed ID: 12186961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine stress protocols for myocardial perfusion imaging.
    Bokhari S; Ficaro EP; McCallister BD
    J Nucl Cardiol; 2007; 14(3):415-6. PubMed ID: 17556176
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the diagnostic value of 2D strain stress echocardiography, myocardial perfusion scintigraphy, and Duke treadmill score in patients suspected of coronary artery disease.
    Ejlersen JA; Poulsen SH; Mortensen J; May O
    Echocardiography; 2016 Oct; 33(10):1523-1531. PubMed ID: 27398624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The routine use of sublingual GTN with resting 99Tcm-tetrofosmin myocardial perfusion imaging.
    Thorley PJ; Sheard KL; Wright DJ; Sivananthan UM
    Nucl Med Commun; 1998 Oct; 19(10):937-42. PubMed ID: 10234673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine challenge and boost protocols: new tools for myocardial perfusion imaging.
    Hurwitz R; Lyons K; Taketa R
    Clin Nucl Med; 1999 Feb; 24(2):92-3. PubMed ID: 9988063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging.
    Hoffmeister C; Preuss R; Weise R; Burchert W; Lindner O
    J Nucl Cardiol; 2014 Dec; 21(6):1223-9. PubMed ID: 25124825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early post-stress pulmonary uptake of 99mTc tetrofosmin during exercise (SPECT) myocardial perfusion imaging: correlation with haemodynamic, perfusion and function parameters.
    Georgoulias P; Demakopoulos N; Kontos A; Xaplanteris P; Xydis K; Fezoylidis I
    Nucl Med Commun; 2006 Feb; 27(2):119-26. PubMed ID: 16404224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity, specificity and accuracy of stress SPECT myocardial perfusion imaging for detection of coronary artery disease in the distribution of first-order branch vessels, using an anatomical matching of angiographic and perfusion data.
    Schwartz JG; Johnson RB; Aepfelbacher FC; Parker JA; Chen L; Azar RR; Parker RA; Danias PG
    Nucl Med Commun; 2003 May; 24(5):543-9. PubMed ID: 12717072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.